A genome-wide association study of metabolic traits in human urine

Nature Genetics

Volumn 43, Issue 6, 2011, Pages 565-569

  Suhre, Karsten ^a,b,g   Wallaschofski, Henri ^c   Raffler, Johannes ^a,b   Friedrich, Nele ^c   Haring, Robin ^c   Michael, Kathrin ^c   Wasner, Christina ^c   Krebs, Alexander ^c   Kronenberg, Florian ^d   Chang, David ^e   Meisinger, Christa ^a   Wichmann, H Erich ^a,b,f   Hoffmann, Wolfgang ^c   Völzke, Henry ^c   Völker, Uwe ^c   Teumer, Alexander ^c   Biffar, Reiner ^c   Kocher, Thomas ^c   Felix, Stephan B ^c   Illig, Thomas ^a   Kroemer, Heyo K ^c   Gieger, Christian ^a   Römisch Margl, Werner ^a   Nauck, Matthias ^c   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e Chenomx Inc   (Canada)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; ALANINE GLYOXYLATE AMINOTRANSFERASE 2; ARYLAMINE ACETYLTRANSFERASE; MEMBRANE PROTEIN; SLC6A20 PROTEIN; SLC7A9 PROTEIN; UNCLASSIFIED DRUG;

ACIDURIA; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DETOXIFICATION; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC TRAIT; GENOTYPE; HUMAN; IMINOGLYCINURIA; KIDNEY METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; URINALYSIS; URINE;

AMINO ACID TRANSPORT SYSTEMS, BASIC; AMINOISOBUTYRIC ACIDS; ARYLAMINE N-ACETYLTRANSFERASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; REPRODUCIBILITY OF RESULTS;

EID: 79957604338     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.837     Document Type: Article

References (35)

1. Gieger, C. et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 4, e1000282 (2008).
2. Illig, T. et al. A genome-wide perspective of genetic variation in human metabolism. Nat. Genet. 42, 137-141 (2010).
3. Tanaka, T. et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet. 5, e1000338 (2009).
4. Hicks, A.A. et al. Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet. 5, e1000672 (2009).
5. Weljie, A.M., Newton, J., Mercier, P., Carlson, E. & Slupsky, C.M. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal. Chem. 78, 4430-4442 (2006).
6. Altmaier, E. et al. Bioinformatics analysis of targeted metabolomics-uncovering old and new tales of diabetic mice under medication. Endocrinology 149, 3478-3489 (2008). (Pubitemid 351919596)
7. Suhre, K. et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5, e13953 (2010).
8. Crumpler, H.R., Dent, C.E., Harris, H. & Westall, R.G. β-Aminoisobutyric acid (α-methyl-β-alanine); a new amino-acid obtained from human urine. Nature 167, 307-308 (1951).
9. Harris, H. Family studies on the urinary excretion of beta-aminoisobutyric acid. Ann. Eugen. 18, 43-49 (1953).
10. Yanai, J., Kakimoto, Y., Tsujio, T. & Sano, I. Genetic study of beta-aminoisobutyric acid excretion by Japanese. Am. J. Hum. Genet. 21, 115-132 (1969).
11. Kakimoto, Y., Taniguchi, K. & Sano, I. D-beta-aminoisobutyrate: pyruvate aminotransferase in mammalian liver and excretion of beta-aminoisobutyrate by man. J. Biol. Chem. 244, 335-340 (1969).
12. van Kuilenburg, A.B. et al. β-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Hum. Mol. Genet. 13, 2793-2801 (2004).
13. Scriver, C.R. & Perry, T.L. Disorders of omega-amino acids in free and peptide-linked forms. in The Metabolic Basis of Inherited Disease Vol. I (eds. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D.) 755-771 (McGraw-Hill, New York, 1989).
14. Rodionov, R.N., Murry, D.J., Vaulman, S.F., Stevens, J.W. & Lentz, S.R. Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production. J. Biol. Chem. 285, 5385-5391 (2010).
15. Kayrak, M. et al. Association between exaggerated blood pressure response to exercise and serum asymmetric dimethylarginine levels. Circ. J. 74, 1135-1141 (2010).
16. Wilson Tang, W.H. et al. Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur. Heart J. 29, 2506-2513 (2008).
17. Vallance, P., Leone, A., Calver, A., Collier, J. & Moncada, S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572-575 (1992).
18. Fliser, D. et al. Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J. Am. Soc. Nephrol. 16, 2456-2461 (2005). (Pubitemid 41725064)
19. Ravani, P. et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J. Am. Soc. Nephrol. 16, 2449-2455 (2005). (Pubitemid 41725063)
20. Leiper, J. et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat. Med. 13, 198-203 (2007).
21. Sanderson, S., Salanti, G. & Higgins, J. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. Am. J. Epidemiol. 166, 741-751 (2007). (Pubitemid 47428907)
22. Deeken, J.F. et al. A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform. Pharmacogenomics J. 10, 191-199 (2010).
23. Teslovich, T.M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
24. Daly, A.K. Drug-induced liver injury: past, present and future. Pharmacogenomics 11, 607-611 (2010).
25. Soranzo, N. et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat. Genet. 41, 1182-1190 (2009).
26. Scott, C.R. The genetic tyrosinemias. Am. J. Med. Genet. C. Semin. Med. Genet. 142C, 121-126 (2006).
27. Mattoo, A. & Goldfarb, D.S. Cystinuria. Semin. Nephrol. 28, 181-191 (2008).
28. Evan, A.P. et al. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 69, 2227-2235 (2006). (Pubitemid 43882110)
29. Köttgen, A. et al. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 42, 376-384 (2010).
30. Chambers, J.C. et al. Genetic loci influencing kidney function and chronic kidney disease. Nat. Genet. 42, 373-375 (2010).
31. Takanaga, H., Mackenzie, B., Suzuki, Y. & Hediger, M.A. Identification of mammalian proline transporter SIT1 (SLC6A20) with characteristics of classical system imino. J. Biol. Chem. 280, 8974-8984 (2005). (Pubitemid 40409589)
32. Bröer, S. et al. Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. J. Clin. Invest. 118, 3881-3892 (2008).
33. Volzke, H. et al. Cohort profile: the Study of Health in Pomerania. Int. J. Epidemiol. 40, 294-307 (2011).
34. John, U. et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz. Praventivmed. 46, 186-194 (2001). (Pubitemid 32747278)
35. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)